🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Apixaban is an anticoagulant (also known as blood thinner) approved by the ...
Status
Completed
Location
Thomas Jefferson University Hosptial
Start Date
2014-11
Trial ID
NCT02270918
Prospective, randomized, double blind trial. The rationale of the study is ...
Status
Completed
Location
IRCCS Policlinico San Donato
Start Date
2011-11
Trial ID
NCT01471730
Treatments Being Tested
The purpose of this study is to assess the independent effects of both a 4-...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-27
Trial ID
NCT02561923
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Status
Terminated
Location
UAB Hospital
Start Date
2023-03-28
Trial ID
NCT05568888
The purpose of this study is to evaluate efficacy and safety of a Prothromb...
Status
Completed
Location
Nippon Medical School Hospital
Start Date
2014-10
Trial ID
NCT02281201
Treatments Being Tested
Patients who undergo percutaneous coronary intervention (PCI) are commonly ...
Status
Recruiting
Location
Istituto Cardiocentro Ticino
Start Date
2026-04-20
Trial ID
NCT07582835
Treatments Being Tested
This study is a multicenter, prospective, single-arm exploratory clinical t...
Status
Recruiting
Location
Institute of haematology and Blood diseases hospital
Start Date
2026-03-01
Trial ID
NCT07406139
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of JNJ-6...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-14
Trial ID
NCT02949206
Treatments Being Tested
The purpose of the aPCC-emicizumab safety study is to investigate the hemos...
Status
Recruiting
Location
Children's Healthcare of Atlanta
Start Date
2026-09
Trial ID
NCT04563520
Treatments Being Tested
The purpose of this study is to assess the use of 2 different Prothrombin C...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01656330
Treatments Being Tested